Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Charnigo

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
JACC. Basic to Translational Science|September 4, 2018
Ticagrelor Reduces Thromboinflammatory Markers in Patients With PneumoniaTravis R Sexton, Guoying Zhang, Tracy E Macaulay, et al.
Southern Medical Journal|July 4, 2013
Fibrinolytic therapy versus primary percutaneous coronary interventions for ST-segment elevation myocardial infarction in Kentucky: time to establish systems of care?Eric L Wallace, John R Kotter, Richard Charnigo, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trialKristofer Dosh, Peter B Berger, Steven Marso, et al.
Sexual Health|July 4, 2014
Condom use motivations and selected behaviours with new versus established sex partnersRichard A Crosby, Robin R Milhausen, Cynthia A Graham, et al.
International Journal of Cardiology|May 29, 2016
Digoxin and short term mortality after acute STEMI: Results from the MAGIC trialMohamed Metawee, Richard Charnigo, Gustavo Morales, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 19, 2008
Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathwayZehra Pamuklar, Jin Sun Lee, Hsin-Yuan Cheng, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|April 12, 2014
Likelihood of Condom Use When Sexually Transmitted Diseases Are Suspected: Results From a Clinic SampleRichard A Crosby, Robin R Milhausen, Cynthia A Graham, et al.
Pacing and Clinical Electrophysiology : PACE|February 4, 2017
Acute Effects of Implantable Cardioverter-Defibrillator Shocks on Biomarkers of Myocardial Injury, Apoptosis, Heart Failure, and Systemic InflammationJordan Brewster, Travis Sexton, Gary Dhaliwal, et al.
The Journal of Invasive Cardiology|September 7, 2006
Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularizationPranab Das, David J Moliterno, Richard Charnigo, et al.
Hypertension (Dallas, Tex. : 1979)|August 26, 2015
Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male miceFrederique Yiannikouris, Yu Wang, Robin Shoemaker, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
JACC. Basic to Translational Science|September 4, 2018
Ticagrelor Reduces Thromboinflammatory Markers in Patients With PneumoniaTravis R Sexton, Guoying Zhang, Tracy E Macaulay, et al.
Southern Medical Journal|July 4, 2013
Fibrinolytic therapy versus primary percutaneous coronary interventions for ST-segment elevation myocardial infarction in Kentucky: time to establish systems of care?Eric L Wallace, John R Kotter, Richard Charnigo, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trialKristofer Dosh, Peter B Berger, Steven Marso, et al.
Sexual Health|July 4, 2014
Condom use motivations and selected behaviours with new versus established sex partnersRichard A Crosby, Robin R Milhausen, Cynthia A Graham, et al.
International Journal of Cardiology|May 29, 2016
Digoxin and short term mortality after acute STEMI: Results from the MAGIC trialMohamed Metawee, Richard Charnigo, Gustavo Morales, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 19, 2008
Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathwayZehra Pamuklar, Jin Sun Lee, Hsin-Yuan Cheng, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|April 12, 2014
Likelihood of Condom Use When Sexually Transmitted Diseases Are Suspected: Results From a Clinic SampleRichard A Crosby, Robin R Milhausen, Cynthia A Graham, et al.
Pacing and Clinical Electrophysiology : PACE|February 4, 2017
Acute Effects of Implantable Cardioverter-Defibrillator Shocks on Biomarkers of Myocardial Injury, Apoptosis, Heart Failure, and Systemic InflammationJordan Brewster, Travis Sexton, Gary Dhaliwal, et al.
The Journal of Invasive Cardiology|September 7, 2006
Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularizationPranab Das, David J Moliterno, Richard Charnigo, et al.
Hypertension (Dallas, Tex. : 1979)|August 26, 2015
Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male miceFrederique Yiannikouris, Yu Wang, Robin Shoemaker, et al.
Pageof 11